- Home
- SFWL vs BTMD Comparison
SFWL vs BTMD Comparison
Compare SFWL & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFWL | BTMD |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.4M | 90.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SFWL | BTMD |
|---|---|---|
| Price | $0.80 | $2.71 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 13.7K | ★ 132.4K |
| Earning Date | 08-27-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 31.68 | ★ 270.48 |
| EPS | 0.14 | ★ 0.78 |
| Revenue | ★ $540,461,000.00 | $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | $5.64 | ★ $3.47 |
| Revenue Growth | ★ 21.10 | 1.34 |
| 52 Week Low | $0.56 | $2.32 |
| 52 Week High | $1.29 | $6.70 |
Technical Indicators
Market Signals| Indicator | SFWL | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 51.62 |
| Support Level | $0.56 | $2.32 |
| Resistance Level | $0.96 | $2.90 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 61.04 | 51.22 |
Price Performance
Historical ComparisonAbout SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.